New drug shows promise for rare liver disease in kids
NCT ID NCT05543174
First seen Jan 31, 2026 · Last updated May 21, 2026 · Updated 14 times
Summary
This study tested a drug called TAK-625 in 7 Japanese children with Alagille Syndrome, a rare liver disease. The goal was to see if the drug could lower bile acid levels and reduce severe itching. Participants took the drug for up to 34 months and had regular clinic visits. Results will help determine the right dose for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALAGILLE SYNDROME (ALGS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Juntendo University Hospital
Bunkyo-ku, Tokyo, Japan
-
Kindai University Nara Hospital
Ikoma, Nara, Japan
-
Kyoto University Hospital
Kyoto, Japan
-
Miyagi Children's Hospital
Sendai, Miyagi, Japan
-
Osaka University Hospital
Suita, Osaka, Japan
-
Saitama Prefectural Children's Medical Center
Saitama, Japan
-
University of Tsukuba Hospital
Tsukuba, Ibaraki, Japan
-
Yokohamashi Tobu Hospital
Yokohama, Kanagawa, Japan
Conditions
Explore the condition pages connected to this study.